The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans.
about
Omega-3 fatty acids and depression: scientific evidence and biological mechanismsMolecular and functional properties of P2X receptors--recent progress and persisting challengesPathogenetic and Therapeutic Applications of Tumor Necrosis Factor-α (TNF-α) in Major Depressive Disorder: A Systematic ReviewHIV/Hepatitis C Virus-Coinfected Virologic Responders to Pegylated Interferon and Ribavirin Therapy More Frequently Incur Interferon-Related Adverse Events Than Nonresponders DoPeripheral Inflammatory Parameters in Late-Life Depression: A Systematic ReviewQuinolinic Acid Responses during Interferon-α-Induced Depressive Symptomatology in Patients with Chronic Hepatitis C Infection - A Novel Aspect for Depression and Inflammatory HypothesisInfection-induced proinflammatory cytokines are associated with decreases in positive affect, but not increases in negative affect.A biobehavioral perspective on depressive symptoms in patients with cerebral astrocytoma.The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus.C-reactive protein is elevated in atypical but not nonatypical depression: data from the National Health and Nutrition Examination survey (NHANES) 1999-2004.The puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation.Dissociative symptoms reflect levels of tumor necrosis factor alpha in patients with unipolar depression.Molecular markers of radiation-related normal tissue toxicity.Characterization of Induced Pluripotent Stem Cell-derived Human Serotonergic Neurons.Transgenic models for cytokine-induced neurological disease.Neural circuitry underlying the interaction between emotion and asthma symptom exacerbationState of the science: depression and type 2 diabetes.Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.Pegylated interferon pharmacokinetics and self-reported depressive symptoms during antiviral treatment for chronic hepatitis C.Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review.Nuclear factor kappa B in the dorsal raphe of macaques: an anatomical link for steroids, cytokines and serotonin.Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attemptsThe TNF-alpha system: functional aspects in depression, narcolepsy and psychopharmacologyHigh frequency and intensity of drinking may attenuate increased inflammatory cytokine levels of major depression in alcohol-use disorders.Emerging biobehavioral factors of fatigue in sickle cell diseaseUrinary interleukin-8 is a biomarker of stress in emergency physicians, especially with advancing age--the JOBSTRESS* randomized trialDirectionality of the relationship between depressive symptom dimensions and C-reactive protein in patients with acute coronary syndromesThe Utility of Animal Models in Understanding Links between Psychosocial Processes and Cardiovascular HealthProinflammatory cytokines in the prefrontal cortex of teenage suicide victims.Fatigue in medical residents leads to reactivation of herpes virus latencyPathophysiology of cancer-related fatigueA review of stress-relapse interactions in multiple sclerosis: important features and stress-mediating and -moderating variables.Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute?Depressive symptoms are associated with tumor necrosis factor alpha in systemic lupus erythematosus.Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases.The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines.Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition?Cytokines associated with toxicity in the treatment of recurrent glioblastoma with afliberceptToxicity as a result of immunostimulation by biologics.Exploration of depressive symptoms in African American cancer patients
P2860
Q21284717-330FC84A-B3D9-49F8-9F86-6B28E2AA7E08Q24617046-D202CD5D-5744-453D-86B5-7816C8E5F834Q26749017-16EA4E40-4B7E-4D37-AAD4-4849EFA4706DQ27491342-3CEE8BDE-1BE8-4622-9833-57C25E5EB8FEQ28079484-E0377A9D-A8D3-477A-8824-FE94D7F82DA3Q28607691-D01633CB-5051-4FC1-BB90-FEF29E250D78Q30439385-88605D8E-1057-447F-AC1F-3C16C981AC61Q30451270-05AE8E0F-341E-4E0D-BD0B-D930BEE51852Q30476952-DD2A88E7-0753-4571-B966-999B88B61F47Q30620309-C868DD1E-A431-432B-A369-594BD9201F5CQ33351796-81029021-4C47-4800-AB93-FBAEBC202DEAQ33559292-567FA4E0-FD27-4C3F-9C2F-A4FA86A028C9Q33568202-C67DE457-BAA3-44E8-B679-F2A751FB6EB3Q33645683-E519FBC9-E4D0-4082-8C11-B824AFC2BEE0Q33926168-70C77DC0-303C-49F8-9D24-E9455EB1BF92Q33939748-E58DF280-7608-478F-8E2A-AD87881E0C49Q34098494-37F71F56-58CE-410D-A7FD-DAE45F5C056FQ34240254-C276E614-086A-4184-BE5C-4EABD72A0FDEQ34262438-BD7B669D-49DA-486B-8111-3E4596EE834AQ34384181-4CCB92A8-5D4C-4B4C-894F-4558F8C0ACB6Q34480534-C10B59DA-9CEB-4D9D-92A5-2DFBFD9AC30EQ34594318-FC1C4F0C-9887-4A98-A3CB-216C74552E48Q34608619-1C3BAFF5-5508-47D5-A61B-4D83E40E9998Q34637905-3D77FDC7-3E10-4A7A-9777-9158B9BBDDAAQ34792799-1B3F8B1B-766A-4476-BB26-BBFFE832DF89Q34971798-8E52DB56-C392-4AD9-9CC9-5CF429201C3EQ35032401-EA8053C6-99D8-42BC-B7C2-B466B7B28770Q35227472-8F307FB4-E3E3-485F-9B24-0E28B0607AC2Q35573452-CEC2C4AE-F3E0-4DAA-9F88-25AC5CAC913EQ35649322-C65FD321-F9B1-4406-AE9E-2A86BE65803CQ35763344-89A7B4AD-42D0-4734-A623-C6B0E8B6CB8CQ36206179-6B7163C1-5F12-47BA-BBF8-F0CBFD50845FQ36418455-6A1918E7-7A35-4F26-91B8-A1EC350E7E0EQ36433143-6CF05BFB-6930-433C-AF21-FDEB563DB4F6Q36541287-9ACCC611-EEED-49E6-869D-716539EB453BQ36559288-35B1DC8B-999B-46D9-AD91-0374138CBD6EQ36626299-4F4EE0F3-43D2-4ED4-B1E2-B4E9F65BA76AQ36712746-B9562B64-01F2-4873-8CA9-D0C2C0A05A2BQ36788414-4D864B91-1F89-4A63-8EB6-5E2EDAEDC43FQ36810378-27049F42-444D-46C5-8A6E-86B52316609F
P2860
The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans.
@ast
The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans.
@en
type
label
The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans.
@ast
The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans.
@en
prefLabel
The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans.
@ast
The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans.
@en
P1476
The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans.
@en
P304
P356
10.1017/S1461145702003103
P577
2002-12-01T00:00:00Z